文献速递生殖医学

胚胎分割产生的人类双胎胚胎在辅助生殖与研究中的潜力

Potential of human twin embryos generated by embryo splitting in assisted reproduction and research.
PubMed 文献 · Hum Reprod Update · 2017-01-01

胚胎分割或双胎生成在兽医领域已用20余年,1993年首次报道人类胚胎分割引发伦理争议,各国法律多将克隆定义为核移植而未提胚胎分割,仅英国将两者同列克隆立法,美国生殖医学学会伦理委员会认为以改善IVF疗效为目的的研究在伦理上可接受。本文综述人类与非人灵长类胚胎分割实验,检索PUBMED和Google Scholar,发现相关研究极少且争议大,部分认为未来可用于生殖医学,部分认为体外人类双胎胚胎不适合临床及研究。

要点

  • 胚胎分割在兽医领域已是标准实践,但在人类和非人灵长类研究极少且争议大。
  • 多数国家法律将克隆定义为核移植而未提及胚胎分割,仅英国将两者同列克隆立法。
  • 美国生殖医学学会伦理委员会认为以改善IVF疗效为目的的胚胎分割研究在伦理上可接受。

核心结论

  • 人类和非人灵长类胚胎分割研究极少,已发表材料尤其人类胚胎研究存在争议,部分认为未来可用于生殖医学,部分认为体外人类双胎胚胎不适合临床及研究。
  • 卵裂球活检式胚胎分割似乎不适合临床或研究目的,而胚胎二分法尚未在人类胚胎中测试。

研究设计与样本

  • 综述,通过PUBMED和Google Scholar数据库检索人类和非人灵长类胚胎分割研究。
  • 检索关键词为「胚胎分割」和「胚胎双胎生成」,单独或与其他前植入胚胎生物学相关短语组合使用。

主要发现

  • 兽医领域使用胚胎分割或双胎生成已超过20年,用于产生具有理想遗传特征的单卵双胎。
  • 1993年首次报道人类胚胎分割,引发关于人类胚胎克隆的激烈伦理辩论。
  • 1997年多利羊出生后,国际社会承认相关道德论证的复杂性并对人类生殖性克隆表示担忧。
  • 一些国家通过法律、法令或官方声明制定禁令,但一般将克隆定义为通过核移植产生的胚胎,未提及胚胎分割。
  • 只有英国将胚胎分割和核移植同时纳入克隆立法。

关键数值与推荐

  • 美国生殖医学学会伦理委员会对移植两个或以上人工创造的同基因组胚胎以产生单次妊娠没有重大伦理异议。
  • 该委员会声明:「由于胚胎分割有潜力改善不孕症IVF治疗的疗效,研究该技术的研究在伦理上可接受」。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 在人类和非人灵长类中进行的研究非常有限。
  • 已发表材料,特别是人类胚胎研究,存在争议。
  • 胚胎二分法尚未在人类胚胎中测试。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Embryo splitting or twinning has been widely used in veterinary medicine over 20 years to generate monozygotic twins with desirable genetic characteristics. The first human embryo splitting, reported in 1993, triggered fierce ethical debate on human embryo cloning. Since Dolly the sheep was born in 1997, the international community has acknowledged the complexity of the moral arguments related to this research and has expressed concerns about the potential for reproductive cloning in humans. A number of countries have formulated bans either through laws, decrees or official statements. However, in general, these laws specifically define cloning as an embryo that is generated via nuclear transfer (NT) and do not mention embryo splitting. Only the UK includes under cloning both embryo splitting and NT in the same legislation. On the contrary, the Ethics Committee of the American Society for Reproductive Medicine does not have a major ethical objection to transferring two or more artificially created embryos with the same genome with the aim of producing a single pregnancy, stating that 'since embryo splitting has the potential to improve the efficacy of IVF treatments for infertility, research to investigate the technique is ethically acceptable'. OBJECTIVE AND RATIONALE: Embryo splitting has been introduced successfully to the veterinary medicine several decades ago and today is a part of standard practice. We present here an overview of embryo splitting experiments in humans and non-human primates and discuss the potential of this technology in assisted reproduction and research. SEARCH METHODS: A comprehensive literature search was carried out using PUBMED and Google Scholar databases to identify studies on embryo splitting in humans and non-human primates. 'Embryo splitting' and 'embryo twinning' were used as the keywords, alone or in combination with other search phrases relevant to the topics of biology of preimplantation embryos. OUTCOMES: A very limited number of studies have been conducted in humans and non-human primates. The published material, especially the studies with human embryos, is controversial. Some reports suggest that twinning technology will find clinical use in reproductive medicine in the future, whereas others conclude the opposite that human twin embryos created in vitro are unsuitable not only for clinical, but also for research, purposes. WIDER IMPLICATIONS: The blastomere biopsy technique of embryo splitting seems to be unsuitable for either clinical or research purposes; however, embryo bisection, a preferable method of cloning in veterinary medicine, has not yet been tested on human embryos.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Noli L, Ogilvie C, Khalaf Y, et al. Potential of human twin embryos generated by embryo splitting in assisted reproduction and research. Hum Reprod Update. 2017. PMID: 27852683. doi:10.1093/humupd/dmw041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。